Prospective prenatal serum screening for Down syndrome in Venezuela

International Journal of Gynecology and Obstetrics

Volumn 103, Issue 3, 2008, Pages 241-245

  Álvarez Nava, Francisco ^a   Soto, Marisol ^a   Morales Machín, Alisandra ^a   Rojas, Alicia ^a   Urdaneta, Karelis ^a   Cañizález, Jenny ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Fetal Down syndrome; Prenatal diagnosis; Prospective study; Risk estimate; Second trimester maternal serum screening

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; UNCLASSIFIED DRUG; UNCONJUGATED ESTRIOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FALSE POSITIVE RESULT; FEMALE; FETUS; HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; VENEZUELA;

EID: 55949135162     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2008.07.017     Document Type: Article

References (13)

1. Muller F., Forestier F., Dingeon B., and ABA Study Group. Second trimester trisomy 21 maternal serum marker screening: results of a countrywide study of 854,902 patients. Prenat Diagn 22 10 (2002) 925-929
2. Wald N.J., Rodeck C., Hackshaw A.K., Walters J., Chitty L., Mackinson A.M., and SURUSS Research Group. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Techno Assess 7 11 (2003) 1-77
3. Holding S. Current state of screening for Down's syndrome. Ann Clin Biochem 39 Pt 1 (2002) 1-11
4. Wald N.J., Cuckle H.S., Densem J.W., Nanchabral K., Royston P., Charhaddow J.E., et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 297 6653 (1988) 883-887
5. Nørgaard-Pedersen B., Larsen S.O., Arends J., Svenstrup B., and Tabor A. Maternal serum markers in screening for Down syndrome. Clin Genet 37 1 (1990) 35-43
6. Wald N.J., Densem J.W., Smith D., and Klee G.G. Four-marker serum screening for Down's syndrome. Prenat Diagn 14 8 (1994) 707-716
7. Hsieh T.T., Hsu J.J., Cheng P.J., Lee C.N., Jou H.J., and Chen C.P. Total hCG versus free beta-hCG combined with alpha-fetoprotein for Down syndrome screening in Taiwan. Taiwan J Obstet Gynecol 46 3 (2007) 230-235
8. Haddow J.E., Palomaki G.E., Knight G.J., Cunningham G.C., Lustig L.S., and Boyd P.A. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med 330 16 (1994) 1114-1118
9. Cavalli P., Gnocchi E., Pennacchio A., and Morrica B. Dual analyte screening for fetal Down's syndrome in pregnant women over 35 years of age. Prenat Diagn 18 6 (1998) 637-638
10. Gyselaers W.J., Vereecken A.J., Van Herck E.J., Straetmans D.P., Martens G.E., de Jonge E.T., et al. Screening for trisomy 21 in Flanders: a 10 years review of 40.490 pregnancies screened by maternal serum. Europ J Obstet Gynecol Reprod Biol 115 2 (2004) 185-189
11. Saller D.V., Caniek J.A., Kellner L.H., Rose N.C., Garza J., French C.A., et al. Maternal serum Down syndrome analyte levels in pregnancies with resulting from translocations. Am J Obstet Gynecol 177 4 (1997) 879-881
12. Ryall R.G., Staples A.J., Robertson E.F., and Pollard A.C. Improved performance in a prenatal screening programme for Down's syndrome incorporating serum-free hCG subunit analyses. Prenat Diagn 12 4 (1992) 251-261
13. Cuckle H. Biochemical screening for Down syndrome. Eur J Obst Gynecol Reprod Biol 92 1 (2000) 97-101